Given that membrane proteins were easier to target in therapy, GLIPR1 were chosen for further research, which was an oncogene or tumor-suppressed genes in different cancers, but barely understood in gastric cancer [23]. This evidence concerns the gene GLIPR1 and gastric cancer.